Q-omics provides the consensus-scored C1orf232 profile across patient tissues and cancer cell-line models. Additionally, C1orf232 RNA expression shows 2,479 significant protein co-abundance associations, with the highest sampling consensus in CCRCC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for C1orf232 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with C1orf232 in patient tissues and cancer cell lines. In patient samples, C1orf232 shows the broadest associations at the RNA and protein expression levels, with CCRCC recurring as the lineage with the largest associated feature set. In cancer cell lines, C1orf232 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in CNS, while CRISPR and shRNA rows add functional-dependency signals in LUNG_SCLC.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	2,479	CCRCC (1436)	view →
Function (mass-spec)	165	CCRCC (76)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	1,859	CNS (801)	view →
Function (RNA)	616	LUNG_SCLC (343)	view →